395
FAECAL IMMUNOCHEMICAL TEST TO DETECT COLORECTAL NEOPLASIA IN LYNCH SYNDROME – A PROSPECTIVE MULTICENTRE STUDY
Date
May 19, 2024
Tracks
Related Products
COLORECTAL CANCER RISK AFTER POLYP REMOVAL IN FECAL IMMUNOCHEMICAL TEST BASED COLORECTAL CANCER SCREENING
Colonoscopy surveillance intervals are based on the predicted risk of metachronous colorectal cancer (CRC) after polyp removal. Due to the presence of co-existent findings at baseline colonoscopy, risk estimation per specific polyp subtype is difficult…
RISK STRATIFICATION IN FIT-BASED COLORECTAL CANCER SCREENING: INTERVAL CANCER RISK AFTER THE UPPER AGE LIMIT OF SCREENING HAS BEEN REACHED
Colorectal cancer (CRC) screening programmes have been shown effective in reducing CRC incidence and mortality. Risk stratification offers opportunities for further optimisation of screening programmes by better balancing the harms and benefits of screening…
SHOULD WE SCREEN MALES AND FEMALES DIFFERENTLY FOR COLORECTAL CANCER? A COST-EFFECTIVENESS ANALYSIS
Most colorectal cancer (CRC) screening programs use a uniform screening strategy. However, it may be more efficient to screen males and females differently due to (ambivalent) biological and demographic differences between the sexes…
ASSESSING THE EFFICACY OF ENDOSCOPIC GASTRIC CANCER SCREENING BY RACE AND SEX IN THE UNITED STATES
Gastric cancer (GC) incidence is declining and too low in the US to recommend general population screening. However, the risk of developing GC in the US is substantially higher in ethnic minorities, potentially warranting screening in specific population subgroups. While _H…